Premium
Swallowing function after transoral laser microsurgery (TLM) ± adjuvant therapy for advanced‐stage oropharyngeal cancer
Author(s) -
Rich Jason T.,
Liu Jingxia,
Haughey Bruce H.
Publication year - 2011
Publication title -
the laryngoscope
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.181
H-Index - 148
eISSN - 1531-4995
pISSN - 0023-852X
DOI - 10.1002/lary.21406
Subject(s) - swallowing , medicine , dysphagia , surgery , stage (stratigraphy) , radiation therapy , transoral laser microsurgery , cancer , chemoradiotherapy , head and neck cancer , tongue , neck dissection , paleontology , pathology , biology
Objectives/Hypothesis: To perform a longitudinal description of swallowing function following transoral laser microsurgery (TLM) ± adjuvant therapy for advanced‐stage oropharyngeal cancer (OPC) and identify prognostic factors associated with swallowing performance. Study Design: Retrospective analysis and longitudinal descriptive study of swallowing outcomes. Methods: Patients treated with TLM for AJCC stage III–IV OPC at Washington University from 1996 to 2008 were included. A search of medical records and direct patient contact were performed to obtain swallowing function at multiple time points. Persistently poor swallowing at 2 year after surgery was the primary outcome measure. Two year swallowing outcomes stratified by tumor site and T stage are presented. Results: One hundred eighteen patients met criteria for the study (median follow‐up 53.9 months). There were 44 T1's, 41 T2's, 23 T3's and 10 T4's. Forty seven percent received radiotherapy and 41% received chemoradiotherapy. Ninety‐eight percent underwent neck dissection. Patients tolerated TLM well with 82% enjoying good swallowing at 1 month after surgery. During adjuvant therapy, at 3 months, good swallowing dropped to 55%. At 1 and 2 years after TLM, 89% and 88% of patients had good swallowing function, respectively. At 2 years, 9 patients had persistently poor swallowing function. 93% of patients with T1 through T3 enjoyed good swallowing at 2 years. T4 base of tongue disease was associated with persistently poor swallowing function in multivariate analyses ( P = 0.0023), with 40% having good swallowing at 2 years. Preexisting comorbidities and conversion to an open procedure were associated with delayed return of swallowing function, but not with persistently poor swallowing. Seven patients developed late‐onset swallowing dysfunction. Conclusions: Treatment of advanced stage OPC with TLM ± adjuvant therapy results in excellent swallowing outcomes for patients with either T1 to T3 tonsil or T1 to T3 base of tongue resections. A detailed, longitudinal swallowing profile is presented to assist in preoperative counseling.